Cognitive Impairments Clinical Trial
Official title:
Based on the THINC-it Tool to Explore the Characteristics and Related Factors of Cognitive Impairment in the Acute Stage of Unipolar and Bipolar Depression
NCT number | NCT05053204 |
Other study ID # | PWRq2021-59 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 15, 2021 |
Est. completion date | June 30, 2023 |
Cognitive impairment is the core symptom of unipolar and bipolar depression, which seriously affects the prognosis of the disease and the rehabilitation of social function. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. In this study,the THINC-it tool was used to study the characteristics of cognitive impairment in unipolar and bipolar depression by longitudinal follow-up, which provides a theoretical basis for the differential diagnosis of unipolar and bipolar depression. Early identification and intervention of risk factors can improve the prognosis of the disease.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | June 30, 2023 |
Est. primary completion date | October 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: Case group: 1?Participants in psychiatric outpatients and inpatients are able and willing to provide informed consent. 2. The participants were male or female aged between 18 and 60, with junior high school education or above. 3. According to ICD-10 criteria, participants were diagnosed with Unipolar and bipolar depressive disorder. 4. The total score of Young's Mania scale ((YMRS)) of the participants was less than 5 and HAMD-17 was greater than17. 5. Subjects received stable mood stabilizers at least two weeks before the study visit, such as SSRIs antidepressants. 6. The combination or use of supportive psychotherapy is allowed. Control group: 1.it did not meet any of the diagnostic criteria in ICD-10 in the past or at present. 2.18-60 years old, junior high school education or above. 3.Have sufficient audio-visual skills to complete the necessary examinations of the study. 4.Willing to participate in this study, and the informed consent form was signed by the subjects. Exclusion Criteria: 1. Current alcohol and / or substance use disorders. 2. Any drugs that may affect cognitive function, such as psychotropic stimulants, corticosteroids, and receptor blockers. 3. Benzodiazepines were used within 12 hours and alcohol consumption within 8 hours before using the THINC-it tool. 4. The patients have some serious physical conditions. 5. The patients received electroconvulsive therapy ((ECT)) in the past 6 months. 6. They are serious negative suicidal concepts and behaviors. |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Mental Health Center IRB | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Mental Health Center |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the THINC-it Tool | The composite THINC-it tool score is the integrated total score of results from performance on five sub-component cognitive tests of the THINC-it tool. | up to 12 week | |
Secondary | HAMD-17 | Assess the state of depression | up to 12 week | |
Secondary | HAM-A | Assessing anxiety state | up to 12 week | |
Secondary | Pittsburgh Sleep Quality Index,PSQI | Evaluate sleep quality | up to 12 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04470219 -
Digital Support for People With Cognitive Impairment
|
N/A | |
Completed |
NCT01071044 -
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
|
Phase 4 | |
Completed |
NCT02962687 -
Video-Enhanced Care Management for Medically Complex Veterans
|
N/A | |
Completed |
NCT01324024 -
Attention & Memory Impairments in Menopausal Women
|
Phase 4 | |
Recruiting |
NCT02778581 -
Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment
|
N/A | |
Suspended |
NCT00197483 -
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia
|
Phase 2 | |
Completed |
NCT05585424 -
Effectiveness of a Program Based on Observation-action Training (AOT) in Patients With Cognitive Impairment.
|
N/A | |
Completed |
NCT05822596 -
Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability
|
N/A | |
Completed |
NCT02830854 -
Molecular Hydrogen for Cognitive Function and Performance in Elderly
|
Phase 3 | |
Withdrawn |
NCT01986777 -
LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
|
N/A | |
Recruiting |
NCT01466205 -
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
|
Phase 2 | |
Recruiting |
NCT05896189 -
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
|
N/A | |
Not yet recruiting |
NCT06212726 -
RTL Concussion Communication
|
N/A | |
Completed |
NCT02868684 -
Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study
|
||
Recruiting |
NCT04490330 -
Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients
|
||
Completed |
NCT02677987 -
The "Light for the Brain" Study
|
N/A | |
Completed |
NCT02746484 -
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
|
N/A |